Parkinson disease, cancer, and LRRK2 Causation or association?

被引：8
|
作者：
Bandmann, Oliver [1 ]
Cookson, Mark R. [2 ]
机构：
[1] Univ Sheffield, SITraN, Dept Neurosci, Sheffield, S Yorkshire, England
[2] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA
来源：
NEUROLOGY | 2012年 / 78卷 / 11期
关键词：
MUTATIONS;
D O I：
10.1212/WNL.0b013e318249f744
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：772 / 773
页数：2
相关论文
共 50 条
  • [1] LRRK2 and Parkinson Disease
    Daechsel, Justus C.
    Farrer, Matthew J.
    ARCHIVES OF NEUROLOGY, 2010, 67 (05) : 542 - 547
  • [2] Association Between Cancer and LRRK2 Mutations in Parkinson's Disease Patients
    Inzelberg, R.
    Hassin-Baer, S.
    Cohen, O. S.
    Aharon-Peretz, J.
    Schlesinger, I.
    Gershoni, R.
    Djaldetti, R.
    Schechtman, E.
    Friedman, E.
    MOVEMENT DISORDERS, 2010, 25 : S648 - S649
  • [3] Association of LRRK2 Haplotype With Age at Onset in Parkinson Disease
    Xiao, Bin
    Deng, Xiao
    Ng, Ebonne Yu-Lin
    Allen, John Carson, Jr.
    Lim, Shen-Yang
    Ahmad-Annuar, Azlina
    Tan, Eng-King
    JAMA NEUROLOGY, 2018, 75 (01) : 127 - 128
  • [4] LRRK2 mutations in Parkinson disease
    Farrer, M
    Stone, J
    Mata, IF
    Lincoln, S
    Kachergus, J
    Hulihan, M
    Strain, KJ
    Maraganore, DM
    NEUROLOGY, 2005, 65 (05) : 738 - 740
  • [5] LRRK2 Parkinson disease mutations enhance its microtubule association
    Kett, Lauren R.
    Boassa, Daniela
    Ho, Cherry Cheng-Ying
    Rideout, Hardy J.
    Hu, Junru
    Terada, Masako
    Ellisman, Mark
    Dauer, William T.
    HUMAN MOLECULAR GENETICS, 2012, 21 (04) : 890 - 899
  • [6] Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease
    Lai, Dongbing
    Alipanahi, Babak
    Fontanillas, Pierre
    Schwantes-An, Tae-Hwi
    Aasly, Jan
    Alcalay, Roy N.
    Beecham, Gary W.
    Berg, Daniela
    Bressman, Susan
    Brice, Alexis
    Brockman, Kathrin
    Clark, Lorraine
    Cookson, Mark
    Das, Sayantan
    Van Deerlin, Vivianna
    Follett, Jordan
    Farrer, Matthew J.
    Trinh, Joanne
    Gasser, Thomas
    Goldwurm, Stefano
    Gustavsson, Emil
    Klein, Christine
    Lang, Anthony E.
    Langston, J. William
    Latourelle, Jeanne
    Lynch, Timothy
    Marder, Karen
    Marras, Connie
    Martin, Eden R.
    McLean, Cory Y.
    Mejia-Santana, Helen
    Molho, Eric
    Myers, Richard H.
    Nuytemans, Karen
    Ozelius, Laurie
    Payami, Haydeh
    Raymond, Deborah
    Rogaeva, Ekaterina
    Rogers, Michael P.
    Ross, Owen A.
    Samii, Ali
    Saunders-Pullman, Rachel
    Schule, Birgitt
    Schulte, Claudia
    Scott, William K.
    Tanner, Caroline
    Tolosa, Eduardo
    Tomkins, James E.
    Vilas, Dolores
    Trojanowski, John Q.
    ANNALS OF NEUROLOGY, 2021, 90 (01) : 76 - 88
  • [7] LRRK2 kinase in Parkinson's disease
    Alessi, Dario R.
    Sammler, Esther
    SCIENCE, 2018, 360 (6384) : 36 - 37
  • [8] Function of LRRK2 in Parkinson's Disease
    Zhu Fei-Zhou
    Xia Kun
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2010, 37 (10) : 1059 - 1066
  • [9] LRRK2 inhibitor progresses for Parkinson disease
    Katie Kingwell
    Nature Reviews Drug Discovery, 2022, 21 : 558 - 558
  • [10] The Role of LRRK2 in Neurodegeneration of Parkinson Disease
    Rui, Qin
    Ni, Haibo
    Li, Di
    Gao, Rong
    Chen, Gang
    CURRENT NEUROPHARMACOLOGY, 2018, 16 (09) : 1348 - 1357
12345